19
Hz), 15.7 (t, JCF = 4.9 Hz), 14.1. F-NMR (377 MHz, CDCl3) δ - 96.5 (tt, JHF = 16.0, 15.8 Hz). (EI)
m/z (rel intens) 184 (M+, 31), 169 (4), 92 (20), 91 (100), 65 (11).
4.2.8. (2,2-difluoroheptyl)benzene (4h)
This product was prepared according to the above general procedure. Compound 4h appeared as a col-
1
orless oil (15 mg, 68%). H-NMR (400 MHz, CDCl3) δ 7.35-7.27 (m, 5H), 3.13 (t, JHF = 15.9 Hz, 2H),
1.82-1.64 (m, 2H), 1.53-1.45 (m, 2H), 1.34-1.22 (m, 4H), 0.88 (t, J = 7.3 Hz, 3H). 13C-NMR (100 MHz,
CDCl3) δ 133.8 (t, JCF = 4.6 Hz), 130.5, 128.6, 127.4, 124.5 (t, JCF = 241.8 Hz), 43.1 (t, JCF = 26.6 Hz),
35.9 (t, JCF = 24.8 Hz), 31.7, 22.6, 22.0 (t, JCF = 4.4 Hz), 14.1. 19F-NMR (377 MHz, CDCl3) δ - 96.5 (tt,
JHF = 16.5, 16.1 Hz). (EI) m/z (rel intens) 212 (M+, 19), 169 (5), 92 (19), 91 (100), 65 (4).
4.2.9. (2,2-difluoro-3-methylbutyl)benzene (4i)
This product was prepared according to the above general procedure. Compound 4i appeared as a color-
1
less oil (12 mg, 62%). H-NMR (400 MHz, CDCl3) δ 7.36-7.27 (m, 5H), 3.14 (t, JHF = 17.1 Hz, 2H),
13
2.06-1.90 (m, 1H), 1.04 (d, J = 6.9 Hz, 6H). C-NMR (100 MHz, CDCl3) δ 133.7 (t, JCF = 4.2 Hz),
130.5, 128.5, 127.3, 125.6 (t, JCF = 245.3 Hz), 40.6 (t, JCF = 26.4 Hz), 33.8 (t, JCF = 24.2 Hz), 16.0 (t,
JCF = 4.9 Hz). 19F-NMR (377 MHz, CDCl3) δ -105.1 (td, JHF = 16.8, 13.8 Hz). (EI) m/z (rel intens) 184
(M+, 24), 93 (5), 92 (28), 91 (100), 65 (13).
4.2.10. (2-cyclopropyl-2,2-difluoroethyl)benzene (4j)
This product was prepared according to the above general procedure. Cu(MeCN)4PF6 (7.5 mg, 0.02
mmol) was used instead of Pd(MeCN)4(BF4)2 (3). Compound 4j appeared as a colorless oil (14 mg,
58%). 1H-NMR (400 MHz, CDCl3) δ 7.35-7.28 (m, 5H), 3.21 (t, JHF = 15.6 Hz, 2H), 1.21-1.05 (m, 1H),
0.67-0.41 (m, 4H). 13C-NMR (100 MHz, CDCl3) δ 133.7 (t, JCF = 4.6 Hz), 130.6, 128.5, 127.4, 122.9 (t,
19
JCF = 244.5 Hz), 44.3 (t, JCF = 25.2 Hz), 15.5 (t, JCF = 29.5 Hz), 1.5 (t, JCF = 4.6 Hz). F-NMR (377
MHz, CDCl3) δ – 101.8 (dt, JHF = 15.1, 13.1 Hz). (EI) m/z (rel intens) 182 (M+, 14), 147 (17), 117 (11),
91 (100), 65 (11).
4.2.11. (2,2-difluoropropane-1,3-diyl)dibenzene (4k)
This product was prepared according to the above general procedure. Cu(MeCN)4PF6 (7.5 mg, 0.02
mmol) was used instead of Pd(MeCN)4(BF4)2 (3). Compound 4k appeared as a colorless oil (15 mg,
70%). 1H-NMR (400 MHz, CDCl3) δ 7.36-7.28 (m, 6H), 7.25-7.23 (m, 4H), 3.10 (t, JHF = 16.2 Hz, 4H).
13C-NMR (100 MHz, CDCl3) δ 133.4 (t, JCF = 4.2 Hz), 130.7, 128.6, 127.5, 123.3 (t, JCF = 243.6 Hz),
42.6 (t, JCF = 25.8 Hz). 19F-NMR (377 MHz, CDCl3) δ – 94.8 (tt, JHF = 16.5, 16.2 Hz). (EI) m/z (rel in-
tens) 232 (M+, 51), 141 (16), 92 (35), 91 (100), 65 (11).
4.2.12. 1-(difluoromethyl)-2,3-dihydro-1H-indene (4l)
This product was prepared according to the above general procedure using fluoroiodane reagent 1 (56
1
mg, 0.2 mmol). Compound 4l appeared as a colorless oil (8 mg, 48%). H-NMR (400 MHz, CDCl3) δ
7.39-7.31 (m, 1H), 7.25-7.17 (m, 3H), 5.79 (td, JHF = 57.1, 5.5 Hz, 1H), 3.71-3.51 (m, 1H), 3.09-2.80
(m, 2H), 2.37-2.23 (m, 1H), 2.18-1.95 (m, 1H). 13C-NMR (100 MHz, CDCl3) δ 145.1, 128.1, 126.7,
125.6, 125.5, 124.9, 118.3 (t, JCF = 245.2 Hz), 49.2 (t, JCF = 20.1 Hz), 31.6, 25.5 (t, JCF = 4.3 Hz). 19F-
NMR (377 MHz, CDCl3) δ – 118.8 (ddd, JHF =56.9, 38.3, 14.2 Hz). (EI) m/z (rel intens) 168 (M+, 27),
118 (9), 117 (100), 115 (30), 91 (6).
4.2.13. 6,6-difluoro-6,7,8,9-tetrahydro-5H-benzo[7]annulene (4m)
This product was prepared according to the above general procedure. The reaction mixture was stirred at
1
40oC for 4 h. Compound 4m appeared as a colorless oil (10 mg, 61%). H-NMR (400 MHz, CDCl3) δ
7.23-7.13 (m, 3H), 7.12-7.06 (m, 1H), 3.32 (t, JHF = 13.4 Hz, 2H), 2.86-2.76 (m, 2H), 2.28-2.15 (m,
2H), 1.82-1.71 (m, 2H). 13C-NMR (100 MHz, CDCl3) δ 142.2, 132.6 (t, JCF = 7.3 Hz), 131.4, 129.3,